Pioglitazone for the treatment of NASH in patients with prediabetes or type 2 diabetes mellitus

被引：10
|
作者：
Cusi, Kenneth [1 ]
机构：
[1] Univ Florida, Div Endocrinol Diabet & Metab, 1600 SW Archer Rd,Room H-2, Gainesville, FL 32610 USA
来源：
GUT | 2018年 / 67卷 / 07期
关键词：
FATTY LIVER-DISEASE;
D O I：
10.1136/gutjnl-2017-313958
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1371 / 1371
页数：1
相关论文
共 50 条
  • [1] Pioglitazone for the treatment of NASH in patients with prediabetes or type 2 diabetes mellitus-authors' response
    Rotman, Yaron
    Sanyal, Arun J.
    GUT, 2018, 67 (07) : 1372 - 1372
  • [2] Extended treatment with pioglitazone improves liver histology in patients with prediabetes or type 2 diabetes mellitus and NASH
    Cusi, Kenneth
    Orsak, Beverly
    Lomonaco, Romina
    Bril, Fernando
    Ortiz-Lopez, Carolina
    Hecht, Joan
    Webb, Amy
    Tio, Fermin
    Darland, Celia M.
    Hardies, Jean
    HEPATOLOGY, 2013, 58 : 248A - 248A
  • [3] Metabolic Predictors of Response to Pioglitazone Treatment in Patients with Prediabetes or Type 2 Diabetes Mellitus (T2DM) and Nonalcoholic Steatohepatitis (NASH)
    Bril, Fernando
    Sanchez, Paola Portillo
    Maximos, Maryann
    Lomonaco, Romina
    Orsak, Beverly
    Hecht, Joan
    Kalavalapalli, Srilaxmi
    Cusi, Kenneth
    DIABETES, 2015, 64 : A337 - A337
  • [4] Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis
    Lian, Jingxuan
    Fu, Jianfang
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [5] Pioglitazone in the Treatment of Diabetes Mellitus Type 2
    Zach, Herwig
    JOURNAL FUR HYPERTONIE, 2011, 15 (04): : 58 - 58
  • [6] Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus A Randomized Trial
    Cusi, Kenneth
    Orsak, Beverly
    Bril, Fernando
    Lomonaco, Romina
    Hecht, Joan
    Ortiz-Lopez, Carolina
    Tio, Fermin
    Hardies, Jean
    Darland, Celia
    Musi, Nicolas
    Webb, Amy
    Portillo-Sanchez, Paola
    ANNALS OF INTERNAL MEDICINE, 2016, 165 (05) : 305 - +
  • [7] Pioglitazone for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes
    Cusi, K.
    Orsak, B.
    Bril, F.
    Lomonaco, R.
    Hecht, J.
    Ortiz-Lopez, C.
    Tio, F.
    Hardies, J.
    Darland, C.
    Musi, N.
    Webb, A.
    Portillo-Sanchez, P.
    ANNALS OF INTERNAL MEDICINE, 2016, 165 (05) : I15 - I15
  • [8] Effects of Extended Pioglitazone Treatment (PIO) on Bone Metabolism in Patients with Prediabetes and Type 2 Diabetes Mellitus (T2DM)
    Sanchez, Paola Portillo
    Bril, Fernando
    Lomonaco, Romina
    Maximos, Maryann
    Bruder, Jan
    Orsak, Beverly
    Hecht, Joan
    Cusi, Kenneth
    DIABETES, 2014, 63 : A293 - A294
  • [9] Withdrawal of pioglitazone in patients with type 2 diabetes mellitus
    Iwase, M.
    Asano, T.
    Sasaki, N.
    Yoshizumi, H.
    Hiramatsu, S.
    Sakai, Y.
    Ogo, A.
    Iida, M.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (04) : 401 - 408
  • [10] Can Pioglitazone Prevent or Delay Type 2 Diabetes in Patients with Prediabetes?
    Obi, Pamela O.
    AMERICAN FAMILY PHYSICIAN, 2021, 104 (02) : 139 - 140
12345